03692 HANSOH PHARMA
Closed Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2025) | |||
| Current | 8.09X | Oper Margin | 43.6% |
|---|---|---|---|
| LT Debt/Equity | 0.1% | Net Margin | 37.0% |
| Total Debt/Equity | 0.3% | Return on Equity | 15.7% |
| Price/Book | 5.25X | Return on Assets | 13.9% |
| (HKD 33.960) | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
| Net Profit (MHKD) | 6,183.78 | 4,649.44 | 3,612.46 | 2,896.90 | 3,318.15 |
|---|---|---|---|---|---|
| Net Profit Growth (%) | +33.0 | +28.7 | +24.7 | -12.7 | +8.8 |
| Earnings Per Share (HKD) | 1.037 | 0.784 | 0.61 | 0.49 | 0.56 |
| Earnings Per Share Growth (%) | +32.3 | +28.6 | +24.5 | -12.6 | +8.0 |
| Dividend Per Share (HKD) | 0.432 | 0.336 | 0.213 | 0.100 | 0.090 |
| P/E* (X) | 32.94 | 43.57 | 56.03 | 69.76 | 60.96 |
| Yield (%) | 1.26 | 0.98 | 0.62 | 0.29 | 0.26 |
| Dividend Share (%) | 41.62 | 42.90 | 34.92 | 20.42 | 16.06 |
| Book NAV (HKD) | 6.501 | 5.139 | 4.792 | 4.287 | 4.136 |
| Auditors' Opinion | Unqualified | Unqualified | Unqualified | Unqualified | Unqualified |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2026-05-19 21:40:21
Latest Result
| (RMBMn) | 2025-12 | 2024-12 | Chg* (%) | 2023-12 |
| Cover Period (mths) | 12 | 12 | NA | 12 |
|---|---|---|---|---|
| Turnover | 15,028 | 12,261 | +22.6 | 10,104 |
| Operating Result | 6,546 | 5,079 | +28.9 | 3,759 |
| Associates | 0 | 0 | N/A | -2.123 |
| Profit Before Taxation | 6,551 | 5,085 | +28.8 | 3,766 |
| Taxation | 995.12 | 713.357 | +39.5 | 488.652 |
| Profit /( Loss) After Taxation | 5,555 | 4,372 | +27.1 | 3,278 |
| Net Profit | 5,555 | 4,372 | +27.1 | 3,278 |
| Earnings Per Share () | 1.0370 | 0.7840 | +32.3 | 0.6097 |
| Dividend Per Share () | 0.4316 | 0.3363 | +28.3 | 0.2129 |
| Announcement Date | 2026-03-29 | 2025-03-21 | NA | 2024-03-26 |
* Annualised
Last Update Time: 2026-05-19 21:40:26
